Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. C. Hwang, H. L. Lim, Y. S. Kim, K. S. Lee, W. Y. Chung, J. H. Park, S. S. Sheen, K. J. Park (Suwon, Republic Of Korea). Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer. Eur Respir J 2009; 34: Suppl. 53, 2671

Member's Comments

No comment yet.

Related content which might interest you: Nrf2-Dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 Expression of peroxiredoxin I, III and thioredoxin in human lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 102s Year: 2005 Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Source: Eur Respir J 2002; 20: 703-709 Year: 2002 Inhibition of heme oxygenase-1 enhances chemosensitivity of cisplatin in lung cancer cells Source: Eur Respir J 2006; 28: Suppl. 50, 336s Year: 2006 Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004 Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Involvement of proteasome inhibition and p53 accumulation in epithelial apoptosis of lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 101s Year: 2005 Disruption of the HIF-1 pathway in cancer cells Source: Research Seminar 2005 - Adaptations to Hypoxia Year: 2005 N-terminal deletion augments the cell death-inducing activity of BAX in the adenoviral gene delivery to nonsmall cell lung cancers Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Transcriptional regulation of the human osteopontin promoter in non-small cell lung cancer Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 p38 MAPK/MSK1/CREB signal pathway involves in transforming growth factor-β-induced heme oxygenase-1 expression in human lung epithelial cells Source: Eur Respir J 2007; 30: Suppl. 51, 544s Year: 2007 MAPK inhibition modulates Hsp27 phosphorylation and glutathione in lung epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 192s Year: 2006 The role of peroxiredoxins in the radiation-induced damage of lung cancer cells Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Distinct BARD1 isoforms expressed in lung cancer potential targets for treatment Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2 Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Prx1 provides resistance to docetaxel-induced apoptosis in lung cancer cells Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010